亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫(yī)藥中間體

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 五肽-28/五肽-31
五肽-28/五肽-31
單價(jià) 10.00 / g對比
銷量 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
庫存 10000g起訂1g
品牌 成都云希
外觀 白色粉末
功效 皮膚護(hù)理
過期 長期有效
更新 2021-07-05 16:42
 
詳細(xì)信息

PENTAPEPTIDE-28

1.Basic information:

INCI name: PENTAPEPTIDE-28

Reference:  Chondricare IS   

Cas No:

EINECS number: 

Formula:

Molecular:

Purity: >95%

Source: synthetic

Grade: cosmetic

Stability: stable

Solubility: soluble in water

Odor: no

Formulation: available for your reference, please contact us.

MSDS and COA: available for your reference, please contact us.

Delivery: promptly from stock

Appearance: white powder

 

2.Usage:

1. PENTAPEPTIDE-28 Increases aconitase enzymatic activity

2. PENTAPEPTIDE-28 Stimulates cell vitality

 

 

Pentapeptide-31

 

1.Basic information:

INCI name: Pentapeptide-31

Reference: Survixyl IS

Cas No:

EINECS number: 

Formula:

Molecular:

Purity: >95%

Source: synthetic

Grade: cosmetic

Stability: stable

Solubility: soluble in water

Odor: no

Formulation: available for your reference, please contact us.

MSDS and COA: available for your reference, please contact us.

Delivery: promptly from stock

Re*mended dose: 0.5%-1%

Capacity: 600g per month

Appearance: white powder

 

2.Usage:

1. Pentapeptide-31 Helps boost the Stemness Recovery *plex (in vitro, ex vivo)

2. Pentapeptide-31 Helps preserve cells under conditions of stress (in vitro, ex vivo, in vivo)

3.In vivo data from clinical studies demonstrate improved appearance in skin and self-rejuvenation

 

©2025 成都云希化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:41397  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |